Your browser doesn't support javascript.
loading
A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL).
Yoshida, Soichiro; Takahara, Taro; Arita, Yuki; Ito, Masaya; Hayakawa, Sara; Oguchi, Tomohiko; Komai, Yoshinobu; Numao, Noboru; Yuasa, Takeshi; Inoue, Masaharu; Ushijima, Hiroki; Kudo, Shigehiro; Shimano, Yasumasa; Nakamura, Yuki; Uchida, Yusuke; Uehara, Sho; Tanaka, Hajime; Yaegashi, Hiroshi; Izumi, Kouji; Yokoyama, Minato; Matsuoka, Yoh; Yoshioka, Yasuo; Konishi, Koji; Nakanishi, Katsuyuki; Nagahara, Akira; Hirakawa, Akihiro; Koike, Ryuji; Koga, Fumitaka; Nishimura, Kazuo; Mizokami, Atsushi; Yonese, Junji; Kageyama, Yukio; Yoshimura, Ryoichi; Fujii, Yasuhisa.
Afiliação
  • Yoshida S; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8510, Japan. s-yoshida.uro@tmd.ac.jp.
  • Takahara T; Department of Biomedical Engineering, Tokai University School of Engineering, Kanagawa, Japan.
  • Arita Y; Department of Radiology, Advanced Imaging Center, Yaesu Clinic, Tokyo, Japan.
  • Ito M; Department of Radiology, Keio University School of Medicine, Tokyo, Japan.
  • Hayakawa S; Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Oguchi T; Department of Radiation Oncology, Department of Radiology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Komai Y; Department of Genitourinary Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Numao N; Department of Genitourinary Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Yuasa T; Department of Genitourinary Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Inoue M; Department of Genitourinary Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Ushijima H; Department of Urology, Saitama Cancer Center, Saitama, Japan.
  • Kudo S; Department of Radiation Oncology, Saitama Cancer Center, Saitama, Japan.
  • Shimano Y; Department of Radiation Oncology, Saitama Cancer Center, Saitama, Japan.
  • Nakamura Y; Department of Radiation Oncology, Saitama Cancer Center, Saitama, Japan.
  • Uchida Y; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8510, Japan.
  • Uehara S; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8510, Japan.
  • Tanaka H; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8510, Japan.
  • Yaegashi H; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8510, Japan.
  • Izumi K; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Ishikawa, Japan.
  • Yokoyama M; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Ishikawa, Japan.
  • Matsuoka Y; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8510, Japan.
  • Yoshioka Y; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8510, Japan.
  • Konishi K; Radiation Oncology Department, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Nakanishi K; Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Nagahara A; Department of Diagnostic and Interventional Radiology, Osaka International Cancer Institute, Osaka, Japan.
  • Hirakawa A; Department of Urology, Osaka International Cancer Institute, Osaka, Japan.
  • Koike R; Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Koga F; Department of Medical Innovation Promotion Center, Tokyo Medical and Dental University, Tokyo, Japan.
  • Nishimura K; Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Mizokami A; Department of Urology, Osaka International Cancer Institute, Osaka, Japan.
  • Yonese J; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Ishikawa, Japan.
  • Kageyama Y; Department of Genitourinary Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Yoshimura R; Department of Urology, Saitama Cancer Center, Saitama, Japan.
  • Fujii Y; Department of Radiation Therapeutics and Oncology, Tokyo Medical and Dental University, Tokyo, Japan.
BMC Urol ; 23(1): 33, 2023 Mar 06.
Article em En | MEDLINE | ID: mdl-36879257
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Distinções e Prêmios / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials Limite: Humans / Male Idioma: En Revista: BMC Urol Assunto da revista: UROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Distinções e Prêmios / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials Limite: Humans / Male Idioma: En Revista: BMC Urol Assunto da revista: UROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão